Biocon inks agreement with DKSH to distribute generic productsIllustrative image – not actual.
Bio-technology company, Biocon, has signed an agreement with market expansion services provider DKSH for distribution of seven generic products in Singapore and Thailand.

Biocon Pharma, a subsidiary of the bio-tech firm and DKSH Business Unit Healthcare, have inked an agreement in this regard.

Under the terms of the pact, DKSH will gain an exclusive license to register and commercialise the seven generic formulations from various therapeutic areas like diabetology, cardiology, oncology and immunology, which will be sold under Biocon's brand in Singapore and Thailand.

DKSH will manage marketing and sales as well as logistics for Biocon Pharma, helping drive sales growth through its capabilities and strengths in the medical and pharmacy channels.

← All latest storiesBack to top →